|
1
|
Ferlay J, Parkin DM and Steliarova-Foucher
E: Estimates of cancer incidence and mortality in Europe in 2008.
Eur J Cancer. 46:765–781. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bacolod MD and Barany F: Molecular
profiling of colon tumors: the search for clinically relevant
biomarkers of progression, prognosis, therapeutics, and
predisposition. Ann Surg Oncol. 18:3694–3700. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wong WM, Poulsom R and Wright NA: Trefoil
peptides. Gut. 44:890–895. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hoffmann W and Jagla W: Cell type specific
expression of secretory TFF peptides: colocalization with mucins
and synthesis in the brain. Int Rev Cytol. 213:147–181. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Taupin D and Podolsky DK: Trefoil factors:
initiators of mucosal healing. Nat Rev Mol Cell Biol. 4:721–732.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Poulsom R, Hanby AM, Lalani EN, Hauser F,
Hoffmann W and Stamp GW: Intestinal trefoil factor (TFF 3) and pS2
(TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are
co-expressed in normal, hyperplastic, and neoplastic human breast
epithelium. J Pathol. 183:30–38. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Buache E, Etique N, Alpy F, et al:
Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of
human breast cancer cells and mammary tumor development in
TFF1-knockout mice. Oncogene. 30:3261–3273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qu Y, Yang Y, Ma D and Xiao W: Increased
trefoil factor 3 levels in the serum of patients with three major
histological subtypes of lung cancer. Oncol Rep. 27:1277–1283.
2012.PubMed/NCBI
|
|
9
|
Bougen NM, Amiry N, Yuan Y, et al: Trefoil
factor 1 suppression of E-cadherin enhances prostate carcinoma cell
invasiveness and metastasis. Cancer Lett. 332:19–29. 2013.
View Article : Google Scholar
|
|
10
|
Kirikoshi H and Katoh M: Expression of
TFF1, TFF2 and TFF3 in gastric cancer. Int J Oncol. 21:655–659.
2002.PubMed/NCBI
|
|
11
|
Leung WK, Yu J, Chan FK, et al: Expression
of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas,
intestinal metaplasia, and non-neoplastic gastric tissues. J
Pathol. 197:582–588. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yio X, Zhang JY, Babyatsky M, et al:
Trefoil factor family-3 is associated with aggressive behavior of
colon cancer cells. Clin Exp Metastasis. 22:157–165. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Babyatsky M, Lin J, Yio X, et al: Trefoil
factor-3 expression in human colon cancer liver metastasis. Clin
Exp Metastasis. 26:143–151. 2009. View Article : Google Scholar
|
|
14
|
Efstathiou JA, Noda M, Rowan A, et al:
Intestinal trefoil factor controls the expression of the
adenomatous polyposis coli-catenin and the E-cadherin-catenin
complexes in human colon carcinoma cells. Proc Natl Acad Sci USA.
95:3122–3127. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Taupin D, Ooi K, Yeomans N and Giraud A:
Conserved expression of intestinal trefoil factor in the human
colonic adenoma-carcinoma sequence. Lab Invest. 75:25–32.
1996.PubMed/NCBI
|
|
16
|
Lefebvre O, Chenard MP, Masson R, et al:
Gastric mucosa abnormalities and tumorigenesis in mice lacking the
pS2 trefoil protein. Science. 274:259–262. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tanaka T, Nakamura J, Kitajima Y, et al:
Loss of trefoil factor 1 is regulated by DNA methylation and is an
independent predictive factor for poor survival in advanced gastric
cancer. Int J Oncol. 42:894–902. 2013.PubMed/NCBI
|
|
18
|
Tebbutt NC, Giraud AS, Inglese M, et al:
Reciprocal regulation of gastrointestinal homeostasis by SHP2 and
STAT-mediated trefoil gene activation in gp130 mutant mice. Nat
Med. 8:1089–1097. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang YG, Li YF, Wang LP and Zhang Y:
Aberrant expression of trefoil factor 3 is associated with
colorectal carcinoma metastasis. J Cancer Res Ther. 9:376–380.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumours. 7th Edition.
Wiley-Blackwell; Oxford: 2009
|
|
21
|
May FE and Westley BR: Expression of human
intestinal trefoil factor in malignant cells and its regulation by
oestrogen in breast cancer cells. J Pathol. 182:404–413. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hoffmann W: Trefoil factors TFF (trefoil
factor family) peptide-triggered signals promoting mucosal
restitution. Cell Mol Life Sci. 62:2932–2938. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thim L and May FE: Structure of mammalian
trefoil factors and functional insights. Cell Mol Life Sci.
62:2956–2973. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Henry JA, Bennett MK, Piggott NH, Levett
DL, May FE and Westley BR: Expression of the pNR-2/pS2 protein in
diverse human epithelial tumours. Br J Cancer. 64:677–682. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chan VY, Chan MW, Leung WK, Leung PS, Sung
JJ and Chan FK: Intestinal trefoil factor promotes invasion in
non-tumorigenic Rat-2 fibroblast cell. Regul Pept. 127:87–94. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dhar DK, Wang TC, Tabara H, et al:
Expression of trefoil factor family members correlates with patient
prognosis and neoangiogenesis. Clin Cancer Res. 11:6472–6478. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Masiakowski P, Breathnach R, Bloch J,
Gannon F, Krust A and Chambon P: Cloning of cDNA sequences of
hormone-regulated genes from the MCF-7 human breast cancer cell
line. Nucleic Acids Res. 10:7895–7903. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Emami S, Rodrigues S, Rodrigue CM, et al:
Trefoil factor family (TFF) peptides and cancer progression.
Peptides. 25:885–898. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rodrigues S, Rodrigue CM, Attoub S, et al:
Induction of the adenoma-carcinoma progression and Cdc25A-B
phosphatases by the trefoil factor TFF1 in human colon epithelial
cells. Oncogene. 25:6628–6636. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vizoso FJ, Fagilde MC, Corte MD, et al:
Cytosolic levels of an estrogen-induced breast cancer-associated
peptide (TFF1/pS2) in colorectal cancer: clinical significance and
relationship with steroid receptors. Int J Biol Markers.
18:301–310. 2003.
|
|
31
|
Kosriwong K, Menheniott TR, Giraud AS,
Jearanaikoon P, Sripa B and Limpaiboon T: Trefoil factors: tumor
progression markers and mitogens via EGFR/MAPK activation in
cholangiocarcinoma. World J Gastroenterol. 17:1631–1641. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peterson AJ, Menheniott TR, O’Connor L, et
al: Helicobacter pylori infection promotes methylation and
silencing of trefoil factor 2, leading to gastric tumor development
in mice and humans. Gastroenterology. 139:2005–2017. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rivat C, Rodrigues S, Bruyneel E, et al:
Implication of STAT3 signaling in human colonic cancer cells during
intestinal trefoil factor 3 (TFF3) - and vascular endothelial
growth factor-mediated cellular invasion and tumor growth. Cancer
Res. 65:195–202. 2005.PubMed/NCBI
|
